Beta-Blockers in High-Risk Outpatients with Chronic Obstructive Pulmonary Disease are Associated with All-Cause Mortality - The STATUETTE Cohort Study.

Int J Chron Obstruct Pulmon Dis · 2021 · PMC8402979 · PMID 34465987

Europe PMC DOI

hedged sentences

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

borderline significancep = 0.059so close (0.05 < p ≤ 0.1)

Beta-blocker use was associated, although with borderline significance, with increased all-cause mortality (HR 1.37 (95% CI, 0.99 to 1.89, p = 0.059)).

also in 7,017 other papers

borderline significantno p-value reported

Discussion In this cohort study consisting of 950 COPD outpatients followed for 3.5 years, we found a borderline significant association between beta-blocker use and increased all-cause mortality.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.